Higher-Risk Myelodysplastic Syndrome (HR-MDS)

Explore clinical trials studying Higher-Risk Myelodysplastic Syndrome (HR-MDS). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Higher-Risk Myelodysplastic Syndrome (HR-MDS) trial results

Completed

NCT02649790

Conditions: Acute Myeloid Leukemia (AML), Blood Protein Disorders, Bone Marrow Diseases, +33 more
Locations: David Geffen School of Medicine at UCLA Los Angeles, California, United States

Oncology Institute of Hope and Innovation Pasadena, California, United States

Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) Denver, Colorado, United States

View all 46 locations